Stereotaxis, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Stereotaxis, Inc. on May 28, 2008, with the earliest event reported on May 29, 2008. The filing discloses the entry into a material definitive agreement regarding executive compensation and amendments to the company's 2002 Stock Incentive Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and compensation agreements rather than financial performance results.
Material Changes and Agreements
- Executive Employment Amendment: The employment agreement with Michael Kaminski (President and COO) was amended to increase salary continuance upon termination without cause from six months to 12 months. In the event of a change of control where the executive is not offered a comparable position, the amendment provides for 12 months of salary continuance and 100% vesting of unvested options.
- Stock Incentive Plan Amendments: The Compensation Committee approved amendments to the 2002 Stock Incentive Plan forms:
- Incentive Stock Options: Post-termination exercise period extended from 30 days to three months; option term reduced from 10 years to five years.
- Performance Shares: Vesting now occurs on the later of achieving performance criteria or one year following the award date.
- Change of Control: Uniform acceleration of vesting provisions added to Incentive Stock Options, Performance Shares, Restricted Stock, and Stock Appreciation Rights.
- Option Grants: On May 28, 2008, incentive stock options were granted to five Named Executive Officers at an exercise price of $4.97 per share:
- Bevil J. Hogg: 75,000 shares
- Michael Kaminski: 100,000 shares
- James M. Stolze: 37,500 shares
- Douglas Bruce: 25,000 shares
- Melissa Walker: 25,000 shares
Outlook, Risks, and Management Commentary
The filing does not contain forward-looking guidance, management commentary on financial outlook, or specific risk factors beyond the standard disclosure of the terms of the new agreements. The changes to the stock plan and executive contract suggest a strategic alignment of executive incentives with potential change-of-control scenarios and a restructuring of option terms.
Key Facts for Investor Verification
- Verify the total number of shares authorized under the 2002 Stock Incentive Plan to assess the impact of the new grants and plan amendments.
- Confirm the current market price of Stereotaxis stock relative to the $4.97 exercise price of the newly granted options.
- Review the full text of Exhibit 10.1 to understand the specific definitions of "termination without cause" and "change of control" that trigger the enhanced severance for the COO.
- Assess the financial impact of the accelerated vesting provisions in the event of a future acquisition.